Mitral Valve Stenosis



Mitral Valve Stenosis


Megan P. Kostibas

Mary Beth Brady

Colleen G. Koch



INTRODUCTION

The 19th century physician, Jean-Nicolas Corvisart established the diagnostic value of percussion in the physical diagnosis of cardiac disorders. He described the diastolic thrill of mitral stenosis (MS) as “a peculiar rushing like water, difficult to be described, sensible to the hand applied over the precordial region, a rushing which proceeds apparently from the embarrassment which the blood undergoes in passing through an opening which is no longer proportioned to the quantity of fluid which it ought to discharge” (1). As early as 1898, D. W. Samways discussed the potential for performing cardiac surgery in the most severe cases of MS in an article entitled “Cardiac Peristalsis: Its Nature and Effects,” published in The Lancet (2). In the modern era of heart disease, cardiac catheterization has provided hemodynamic information and assessment of the severity of MS. Popovic et al. (3) investigated time-related trends in the use of preoperative invasive hemodynamic measurements in 1,985 patients with isolated valvular stenosis. During the study period, need for invasive hemodynamic measurements acquired during catheterization dramatically decreased, superseded by noninvasive hemodynamic measurements obtained with echocardiography (3). Currently, two-dimensional (2D) and Doppler echocardiography have supplanted cardiac catheterization in providing a complete evaluation of patients with MS (4).


MITRAL VALVE ANATOMY

Morphologically, the mitral valve (MV) apparatus is composed of the left atrial wall, mitral annulus, anterior and posterior MV leaflets, chordal tendons, anterolateral and posteromedial papillary muscles, and left ventricular myocardium (5,6). The valvular tissue can be divided into two commissural regions, the anterolateral commissure and the posteromedial commissure, and two leaflet areas, the anterior and posterior MV leaflets. The anterior mitral leaflet is somewhat triangular in shape, with an attachment to approximately one-third of the circumference of the mitral annulus. It is attached to the fibrous skeleton of the heart, as are the left coronary cusp and half of the noncoronary cusp of the aortic valve. The attachment of the posterior mitral leaflet to the mitral annulus is lengthier than that of the anterior mitral leaflet. Clefts along the free margin of the posterior leaflet allow the identification of individual scallops (5). Although the anterior mitral leaflet base-to-margin dimension is longer than that of the posterior mitral leaflet, and although the basal attachments are different for each leaflet, the two leaflets are nearly identical in overall surface area. Chordal tendons from each papillary muscle attach to both of the MV leaflets. On average, 120 chordal tendons attach to the undersurface of the MV leaflets. The chordal tendons subdivide as they project from the papillary muscles toward the MV leaflets. The spaces between the chordae serve as secondary orifices between the left atrium (LA) and left ventricle (LV) (6).

The normal MV orifice area is approximately 4 to 6 cm2. An orifice area in the range of 2 cm2 causes a minimal elevation in the transvalvular pressure gradient, whereas a valve area of less than 1.4 cm2 is associated with a significant transvalvular pressure gradient and the clinical presentation of MS (7,8,9).


ETIOLOGY OF MITRAL STENOSIS

The causes of MS include the following: rheumatic heart disease, LA myxoma, severe mitral annular calcification, thrombus formation, parachute MV deformity, congenital MS, supravalvular mitral ring, and cor triatriatum (6,10). Figures 9.1 and 9.2 depict a large LA myxoma obstructing mitral inflow.

Throughout the world, the most common cause of MS in adult patients is rheumatic heart disease. In developed countries, rheumatic fever and thus rheumatic MS is much less common (3,6,9). Pathologic features of rheumatic MS include fusion of the commissures; contracture, scarring, and diffuse thickening of the leaflet tissue and subvalvular apparatus; and calcium deposition within the mitral leaflets. This clinically progressive process results in a diminished size of the effective valvular orifice, in addition to valve rigidity as a consequence of the leaflet fibrosis and calcification. As the valve area becomes more restricted, increases in the transvalvular pressure gradient and LA pressure may lead to pulmonary hypertension with tricuspid regurgitation, right ventricular dysfunction, and dyspnea (6,8,9,10).







FIGURE 9.1 A transesophageal echocardiographic mid-esophageal two-chamber image displays a 3- × 6-cm left atrial myxoma causing symptomatic mitral stenosis. The atrial myxoma is visualized prolapsed through the mitral valve into the left ventricular cavity during diastole.


TRANSESOPHAGEAL ECHOCARDIOGRAPHIC EVALUATION OF MITRAL STENOSIS

A discussion of the complete diagnostic evaluation follows, and the chapter concludes with a concise summary of the recommended approach to an accurate diagnosis of MS.


Two-Dimensional Echocardiography

The anatomy of MS can be defined more clearly from multiple imaging planes of 2D transesophageal echocardiography (TEE) than by any other diagnostic modality. On the basis of the pathophysiologic features of rheumatic MS, key features that must be identified include the following: degree of leaflet thickening, amount of calcium deposition, extent of subvalvular involvement, decrement in leaflet mobility, and overall changes in chamber dimensions and functions (11). Related issues, such as involvement of other valve structures, regurgitation and pulmonary hypertension, should also be assessed.






FIGURE 9.2 An atrial myxoma displayed from a transgastric basal short-axis imaging plane occupies a large portion of the mitral orifice. The mitral valve orifice measures 1.86 cm2 in diastole.







FIGURE 9.3 A mid-esophageal four-chamber view of rheumatic mitral stenosis displays the characteristic diastolic “doming” of the anterior mitral leaflet in diastole and an enlarged left atrium. The mitral leaflets are thickened, particularly at their margins, and appear echo-bright secondary to calcium deposition.

Mitral leaflet tissue can display varying degrees of thickening and calcium deposition that cause the MV leaflets to appear “enhanced,” or echo-bright. The “shadow” cast by calcium may obstruct the view of the distal anatomy; one of the strengths of TEE in this circumstance is the ability to view the structures from another plane, so that the operator can see beyond the “shadow.” The standard mid-esophageal (ME) views (four chamber, commissural, two chamber, and long axis) assist in evaluating the extent of disease. The chordal tendons can display varying degrees of thickening and contracture. The transgastric (TG) longaxis imaging plane provides the best information with regard to the extent of subvalvular involvement in the rheumatic process. The characteristic 2D echocardiographic findings associated with rheumatic MS are represented in Figure 9.3 and image Videos 9.1 to 9.3. Rheumatic heart disease results in varying degrees of restricted mitral leaflet motion. In 2D TEE, restricted leaflet motion is characterized by decreased leaflet excursion and by diastolic “doming” of the anterior mitral leaflet. The appearance of “doming” is the result of fusion of the anterior and posterior leaflets along the medial and lateral commissures. The leaflets are restricted or abnormally stenotic at the tips. The maximal amplitude of motion occurs in the mobile midsection, giving the anterior mitral leaflet an arched appearance, convex toward the LV outflow tract in diastole (12,13). Figure 9.3 and image Video 9.1 demonstrate the characteristic “doming” or “hockey stick” deformity of the anterior mitral leaflet in diastole.


Echocardiographic Scoring System

Over 20 years ago, Wilkins et al. (11) published an echocardiographic scoring system to assess MV morphology and its relationship to the success of percutaneous balloon dilation of the MV. Each of the four components of the scoring system is graded on a scale of 0 to 4, such that total scores range from 0 to 16. The four components of the scoring system assess the MV for the pathologic changes characteristically associated with rheumatic heart disease: reduced leaflet mobility, leaflet thickening, subvalvular thickening, and calcification. These investigators reported that a high echocardiographic score (>11), which is representative of advanced leaflet deformity, was associated with a suboptimal outcome after balloon dilation of the MV. A low echocardiographic score (<9) was associated with an optimal outcome (11). Table 9.1 presents the scoring system and describes what each grade on the scale represents for each of the four components. Although this scoring system was developed for patients undergoing mitral balloon dilation, it can serve as a useful guide during the TEE examination of patients with rheumatic MS (see Table 9.1).









TABLE 9.1 Echocardiographic Scoring System



































Grade


Mobility


Subvalvular thickening


Thickening


Calcification


1


Highly mobile valve with only leaflet tips restricted


Minimal thickening just below the mitral leaflets


Leaflets nearly normal in thickness (4-5 mm)


Single area of increased echo-brightness


2


Leaflet mid and base portions have normal mobility


Thickening of chordal structures extending up to one-third of chordal length


Mid leaflets normal, considerable thickening of margins (5-8 mm)


Scattered areas of brightness confined to leaflet margins


3


Valve continues to move forward in diastole, mainly from base


Thickening extending to the distal third of chords


Thickening extending through the entire leaflet (5-8 mm)


Brightness extending into midportion of the leaflets


4


No or minimal forward movement of the leaflets in diastole


Extensive thickening and shortening of all chordal structures extending down to papillary muscles


Considerable thickening of all leaflet tissue (>8-10 mm)


Extensive brightness throughout much of the leaflet tissue


From Wilkins G, Weyman A, Abascal V, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308, with permission.


Standard chamber dimensions can be altered depending on the duration and degree of MS. Typically, an increase in the LA area is associated with chronic volume and pressure overload. Because of the low-flow state, LA spontaneous echo contrast or thrombus formation may be present. Daniel et al. (14) characterized LA spontaneous echo contrast as “dynamic clouds of echoes curling up slowly in a circular or spiral shape within the left atrium.” They found that LA spontaneous echo contrast is useful in identifying those patients with MS who are at increased risk for thromboembolic events. TEE is more sensitive than transthoracic echocardiography in detecting LA spontaneous echo contrast. Since LA spontaneous echo contrast indicates blood stasis and may be a warning of thrombus formation, it is critical to scan the LA completely to exclude thrombus formation (14,15). Figure 9.4 displays an ME view of the LA with a thrombus in the LA appendage.

Diastolic properties of the LV are also affected in rheumatic MS. In patients with severe isolated rheumatic MS, Liu et al. (16) demonstrated reduced LV diastolic compliance. The reduction in compliance appeared to be related to a functional restriction resulting from chordal tethering to a rigid valve apparatus, a finding that was immediately reversed after balloon mitral valvuloplasty. LV systolic performance in patients with severe isolated MS was nearly identical to that in age-matched controls. Chronic elevation in LA pressure can cause
structural alterations in the pulmonary vasculature, leading to pulmonary hypertension and ultimately rightsided heart failure (8,9). TEE evaluation of the right side of the heart may demonstrate varying degrees of right ventricular dysfunction and tricuspid regurgitation. A comprehensive 2D and Doppler TEE examination of the heart should be performed to exclude these associated findings and other valvular pathology.






FIGURE 9.4 A left atrial appendage thrombus (arrow) is visualized from a short-axis imaging plane of the left atrium.








TABLE 9.2 Stages of Mitral Stenosis From the American Heart Association/American College of Cardiology Guidelinesa










































Stage


Definition


Valve anatomy


Valve hemodynamics


Hemodynamic consequences


Symptoms


A


At risk of MS


Mild diastolic doming


Normal transmitral flow velocity


None


None


B


Progressive MS


Commissural fusion, diastolic doming


MVA >1.5 cm2 via planimetry


Increased transmitral flow velocities


MVA >1.5 cm2


PHT <150 ms


Mild-moderate LAE


Normal PA pressures at rest


None


C


Asymptomatic severe MS


Commissural fusion and diastolic doming


MVA ≤1.5 cm2 via planimetry


MVA ≤1.0 cm2 with very severe


MVA ≤1.5 cm2


MVA ≤1.0 cm2 with very severe


PHT ≥150 ms


PHT ≥220 ms with very severe


Severe LAE


Elevated PASP >30 mm Hg


None


D


Symptomatic severe MS


Commissural fusion and diastolic doming


MVA ≤1.5 cm2 via planimetry


MVA ≤1.5 cm2


MVA ≤1.0 cm2 with very severe


PHT ≥150 ms


PHT ≥220 ms with very severe


Severe LAE


Elevated PASP >30 mm Hg


Decreased exercise tolerance


Exertional dyspnea


aFrom Nishimura R et al., 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: Executive Summary. Circulation. 2014;129:2440-2492.


MS, mitral stenosis; LAE, left atrial enlargement; PA, pulmonary artery; PASP, pulmonary artery systolic pressure; PHT, pressure half-time.



Physiologic Assessments

Updated ACC/AHA Guidelines in 2014 emphasized a more contemporary approach to the assessment of MS (17). The central concept is that patients may present in phases of MS progression from stage A to stage D, which represent more than a simple valve area calculation or mean pressure gradient. The guideline assessment for severity includes features of MV anatomy, valve hemodynamics, and hemodynamic consequences, such as left atrial enlargement and elevated pulmonary artery pressures as a result of the valve lesion and patient symptoms. For example, stage A; “At risk of MS” might feature mild MV diastolic doming, normal transmitral flow velocities, and no secondary hemodynamic consequences or patient symptoms; whereas stage D: “Symptomatic severe MS” might feature diastolic doming, commissural fusion, valve area <1.5 cm2, pressure half-time of ≥150 ms, severe left atrial enlargement, elevated pulmonary artery pressures >30 mm Hg, and patient symptoms of limited exercise tolerance (Table 9.2) (17).


Determination of the Pressure Gradient

Normal flow velocity across the MV is less than 1.3 m/s. The pressure drop across a stenotic valve can be calculated from the instantaneous flow velocity by means of the simplified Bernoulli equation (18,19):

Pressure gradient (mm Hg) = 4v2

where v represents the instantaneous velocity.

The equation is modified from the original in that the terms that account for viscous friction and flow acceleration have been eliminated. Since the velocity distal to the obstruction is significantly greater than the velocity proximal to the obstruction, the proximal velocity term can be ignored (18,19). Continuous wave Doppler interrogation of the inflow velocities across the valve is performed with the use of the ME four-chamber, two-chamber, or long-axis view. Following manual tracing of the diastolic spectral profile, the
echocardiographic machine software provides a mean gradient in millimeters of mercury. Figure 9.5 displays a mean gradient measurement across the MV in a patient with MS obtained with continuous wave Doppler and the ME four-chamber view. It is important to note that an increase in forward flow through the mitral orifice, such as occurs in severe mitral valvular regurgitation, can result in a high transmitral gradient although the valve is only mildly stenotic. One, therefore, must be aware that the degree of MS can be overestimated in the face of significant mitral regurgitation (4). Pressure gradients are underestimated if the angle between the sampling beam and the flow vector is large (>20°) (18,20). Visualizing the inflow jet with color Doppler and aligning the sample beam with the color inflow can help minimize this problem (20). In general, a mean gradient of more than 10 mm Hg across a stenotic valve is considered to indicate severe stenosis (21).






FIGURE 9.5 A diastolic spectral profile of mitral inflow has been obtained with continuous wave Doppler in this patient with mitral stenosis. The profile has been traced out, and a mean pressure gradient of 14 mm Hg has been calculated with the software available within the machine. Note that the inflow velocities are close to 2 m/s.


Calculations of Valve Area

The severity of MS is also estimated by calculating the MV area. This can be done with the use of 2D and Doppler echocardiographic techniques.


Planimetry Valve Area

Planimetry is a conceptually simple 2D technique used to calculate the MV area. It involves direct visualization of the MV orifice in diastole from a TG basal short-axis imaging plane and tracing the orifice margins to acquire a valve area measurement in square centimeters (Fig. 9.6). The results obtained with this technique have been shown to correlate well with valve area measurements acquired invasively (3,12,22). Figure 9.6 demonstrates the use of planimetry in calculating the MV area from the TG basal short-axis imaging plane in a patient with rheumatic MS. In order to optimize measurement accuracy, a number of operator “pitfalls” should be recognized when this technique is used. Instrumentation factors are critical in obtaining adequate images for planimetry. For example, if the receiver gain settings are too low, the edges of the valve may be obscured, resulting in “echo dropout,” and the valve area will be overestimated (12). The opposite occurs when the gain settings are set too high, with resultant image saturation and a falsely narrowed valve orifice (23). Inadequate imaging plane orientation is another important measurement error with this technique. The stenotic MV looks like a funnel in diastole, the narrowest part being the commissural tip of the valve. It is critical to scan the MV orifice superiorly to inferiorly to acquire the smallest orifice area. Measuring too superiorly, in the body of the leaflets, can overestimate the valve area (22,23,24). In patients who have undergone mitral valvuloplasty, the valve area may be underestimated because of the inability to measure the extent of the commissural fractures with planimetry.

Only gold members can continue reading. Log In or Register to continue

Apr 16, 2020 | Posted by in ANESTHESIA | Comments Off on Mitral Valve Stenosis
Premium Wordpress Themes by UFO Themes